FDAnews
www.fdanews.com/articles/74971-alliant-pharmaceuticals-adds-rondec-to-its-product-line

ALLIANT PHARMACEUTICALS ADDS RONDEC TO ITS PRODUCT LINE

August 3, 2005

Alliant Pharmaceuticals, Inc. a pediatric specialty pharmaceutical company, has acquired RONDEC(R), a medication for cold and allergy symptoms, from Biovail Corp. (TSX: BVF), a specialty pharmaceutical company based in Ontario, Canada. RONDEC syrup and oral drops, (Brompheniramine maleate, Pseudoephedrine hydrochloride, Dextromethorphan hydrobromide, Carbinoxamine maleate) are decongestant and antihistamine combinations used to treat the symptoms associated with seasonal rhinitis (hay fever) and other types of inflammation in the nose.

Finanzen (http://finanzen.net/news/news_detail.asp?NewsNr=324917)